ISOPROSTANES IN LIVER DISEASE-INDUCED RENAL DYSFUNCTION
异前列腺素在肝病引起的肾功能障碍中的作用
基本信息
- 批准号:6634778
- 负责人:
- 金额:$ 12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2005-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the application)
Liver disease induces a spectrum of renal abnormalities. Early on there is
redistribution of intrarenal RBF; that is there is cortical vasoconstriction
with shunting of RBF towards the juxtamedullary nephrons, which may contribute
to enhanced sodium and water retention. However, the mechanisms leading to
these alterations are not clear. Recent studies have described a new family of
prostaglandin-like compounds, F2-isoprostanes, that are formed in vivo by
free-radical catalyzed peroxidation of arachidonic acid. These compounds are
markers of oxidant injury, possess biological activity and are markedly
elevated in liver disease. Yet their role in the associated renal dysfunction
is poorly understood. We hypothesize that elevated oxidative stress in liver
disease increases F2-isoprostanes, which in turn contribute to the altered
renal hemodynamics. In our first aim, we examine whether oxidative stress via
F2-isoprostanes contributes to the redistribution of intrarenal RBF induced by
chronic bile duct ligation (c-BDL). The rationale for this aim is that c-BDL
increases oxidative stress and causes redistribution of RBF. Thus, using
micro-CT technology, we will examine whether by acutely or chronically blocking
oxidative stress or the F2-isoprostanes receptor reverses or prevents the
redistribution of RBF. The next aims assess the direct actions of isoprostanes,
and what role oxidative stress via isoprostanes plays in the renal vascular
abnormalities of the c-BDL rats. For this, we will study vascular reactivity in
isolated microperfused afferent arterioles dissected from the superficial and
juxtamedullary cortex (s-Af-Arts and jm-Af-Arts respectively), of control and
c-BDL rats. In aim #2 we test the hypothesis that s-Af-Arts are more sensitive
than jm-Af-Arts isoprostane-induced vasoconstriction, which thus may explain
why renal medullary perfusion is preserved despite marked cortical
hypoperfusion. In aim #3 we test the hypothesis that vascular reactivity of
s-Af-Art but not jm-Af-Arts is enhanced in c-BDL compared to controls
(contributing to the above-mentioned redistribution of RBF). If we find that
Af-Art reactivity is altered, we will test the hypothesis that the enhanced
reactivity is due to oxidative stress via increased isoprostanes by determining
whether treatment with antioxidants or isoprostane antagonists improves the
vascular parameters. Finally, because bile acids are very elevated in c-BDL,
and can themselves promote oxidative stress, aim #4 tests the hypothesis that
the elevated bile acids themselves contribute to the enhanced Af-Art reactivity
via their pro-oxidant actions. We will examine the effects that bile acids have
on s- and jm-Af-Art diameter, and reactivity (as in aim #2). This information
will complement that obtained in aim #2 (where the exposure to bile acids is
chronic in vivo rather than acute in vitro). Our proposed application therefore
characterizes the renal vascular actions of oxidative stress and isoprostanes,
and evaluates their role in the c-BDL rats.
描述(改编自应用程序)
肝脏疾病可引起一系列肾脏异常。早些时候,
肾内RBF的重新分布;即存在皮质血管收缩
RBF向延髓肾单位分流,这可能有助于
增加钠和水的保留。然而,导致
这些变化并不清楚。最近的研究描述了一个新的家庭,
前列腺素样化合物,F2-异前列腺素,在体内由
自由基催化的花生四烯酸过氧化反应。这些化合物
氧化损伤标志物,具有生物活性,
在肝病中升高。然而,它们在相关的肾功能障碍中的作用
是很难理解的。我们假设肝脏中氧化应激的升高
疾病增加F2-异前列腺素,这反过来又有助于改变
肾血流动力学在我们的第一个目标中,我们研究是否通过氧化应激,
F2-异前列腺素有助于肾内RBF的重新分布
慢性胆管结扎(c-BDL)。这一目标的基本原理是,
增加氧化应激并引起RBF的重新分布。因此,使用
微CT技术,我们将检查是否通过急性或慢性阻塞
氧化应激或F2-异前列腺素受体逆转或阻止
RBF的再分配下一个目标是评估异前列烷的直接作用,
氧化应激通过异前列腺素在肾血管中起什么作用
c-BDL大鼠的异常。为此,我们将研究血管反应性,
分离微灌注的传入小动脉,
延髓皮质(分别为s-Af-Arts和jm-Af-Arts),对照组和
c-BDL大鼠。在目标#2中,我们测试了s-Af-Arts更敏感的假设
比jm-Af-Arts异前列腺素诱导的血管收缩,这可以解释
为什么尽管有明显的皮质
低灌注在目标3中,我们检验了以下假设:
与对照组相比,c-BDL中s-Af-Art而非jm-Af-Arts增强
(有助于上述RBF的再分配)。如果我们发现
Af-Art反应性改变,我们将测试增强的
反应性是由于氧化应激通过增加异前列腺素,通过测定
用抗氧化剂或异前列烷拮抗剂治疗是否改善了
血管参数最后,因为胆汁酸在c-BDL中非常高,
并且本身可以促进氧化应激,目标#4测试假设,
升高的胆汁酸本身有助于增强Af-Art反应性
通过它们的促氧化作用。我们将研究胆汁酸的作用
关于s-和jm-Af-Art直径和反应性(如在目标#2中)。这些信息
将补充目标#2中获得的结果(其中暴露于胆汁酸是
体内慢性而非体外急性)。因此,我们提出的申请
表征了氧化应激和异前列烷的肾血管作用,
并评价其在c-BDL大鼠中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LUIS A. JUNCOS其他文献
LUIS A. JUNCOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LUIS A. JUNCOS', 18)}}的其他基金
Supressor ANGII Determines Acute & Chronic Renal Injury
ANGII 抑制剂决定急性
- 批准号:
7903713 - 财政年份:2009
- 资助金额:
$ 12万 - 项目类别:
Supressor ANGII Determines Acute & Chronic Renal Injury
ANGII 抑制剂决定急性
- 批准号:
7272010 - 财政年份:2006
- 资助金额:
$ 12万 - 项目类别:
Supressor ANGII Determines Acute & Chronic Renal Injury
ANGII 抑制剂决定急性
- 批准号:
7539817 - 财政年份:2006
- 资助金额:
$ 12万 - 项目类别:
Supressor ANGII Determines Acute & Chronic Renal Injury
ANGII 抑制剂决定急性
- 批准号:
7624278 - 财政年份:2006
- 资助金额:
$ 12万 - 项目类别:
Supressor ANGII Determines Acute & Chronic Renal Injury
ANGII 抑制剂决定急性
- 批准号:
7435400 - 财政年份:2006
- 资助金额:
$ 12万 - 项目类别:
Supressor ANGII Determines Acute & Chronic Renal Injury
ANGII 抑制剂决定急性
- 批准号:
7145529 - 财政年份:2006
- 资助金额:
$ 12万 - 项目类别:
ISOPROSTANES IN LIVER DISEASE-INDUCED RENAL DYSFUNCTION
异前列腺素在肝病引起的肾功能障碍中的作用
- 批准号:
6743769 - 财政年份:2001
- 资助金额:
$ 12万 - 项目类别:
ISOPROSTANES IN LIVER DISEASE-INDUCED RENAL DYSFUNCTION
异前列腺素在肝病引起的肾功能障碍中的作用
- 批准号:
6516805 - 财政年份:2001
- 资助金额:
$ 12万 - 项目类别:
ISOPROSTANES IN LIVER DISEASE-INDUCED RENAL DYSFUNCTION
异前列腺素在肝病引起的肾功能障碍中的作用
- 批准号:
6228868 - 财政年份:2001
- 资助金额:
$ 12万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 12万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 12万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 12万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 12万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 12万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 12万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 12万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 12万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 12万 - 项目类别:
Metabolic and epigenetic regulation of cancer associated fibroblasts by angiotensin II
血管紧张素 II 对癌症相关成纤维细胞的代谢和表观遗传调控
- 批准号:
440714 - 财政年份:2020
- 资助金额:
$ 12万 - 项目类别:
Fellowship Programs














{{item.name}}会员




